(Q47267722)

12 January 2018

title

Interspecies pharmacokinetic comparisons and allometric scaling of napsagatran, a low molecular weight thrombin inhibitor. (English)

1 reference

12 January 2018

1 reference

Lavé T

1

1 reference

12 January 2018

Portmann R

2

1 reference

12 January 2018

Schenker G

3

1 reference

12 January 2018

Gianni A

4

1 reference

12 January 2018

Guenzi A

5

1 reference

12 January 2018

Girometta MA

6

1 reference

12 January 2018

Schmitt M

7

1 reference

12 January 2018

publication date

1 January 1999

1 reference

12 January 2018

Journal of Pharmacy and Pharmacology

published in

1 reference

12 January 2018

volume

51

1 reference

12 January 2018

page(s)

85-91

1 reference

12 January 2018

issue

1

1 reference

12 January 2018

Animal pharmacokinetics and interspecies scaling of FCE 22101, a penem antibiotic.

cites work

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772006

Interspecies scaling of interferon disposition and comparison of allometric scaling with concentration-time transformations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772006

Interspecies scaling of bosentan, a new endothelin receptor antagonist and integration of in vitro data into allometric scaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772006

Interspecies scaling of tolcapone, a new inhibitor of catechol-O-methyltransferase (COMT). Use of in vitro data from hepatocytes to predict metabolic clearance in animals and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772006

Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: application to 10 extensively metabolized drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772006

Man versus beast: pharmacokinetic scaling in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772006

1-Aminocyclopropanecarboxylic acid: mouse to man interspecies pharmacokinetic comparisons and allometric relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772006

First-pass elimination of a peptidomimetic thrombin inhibitor is due to carrier-mediated uptake by the liver. Interaction with bile acid transport systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772006

A new extrapolation method from animals to man: application to a metabolized compound, mofarotene

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772006

An evaluation of the integration of pharmacokinetic and pharmacodynamic principles in clinical drug development. Experience within Hoffmann La Roche

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772006

Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772006

Comparative pharmacokinetics of [14C]metosulam (N-[2,6-dichloro-3-methylphenyl]-5,7-dimethoxy-1,2,4- triazolo[1,5a]-pyrimidine-2-sulfonamide) in rats, mice and dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772006

Evaluation of renal function in rhesus monkeys and comparison to beagle dogs following oral administration of the organic acid triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid)

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772006

21 January 2018

Identifiers

DOI

10.1211/0022357991772006

1 reference

12 January 2018

PubMed ID

10197423

1 reference

12 January 2018